FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

28022211000001106: Canagliflozin 50mg / Metformin 850mg tablets 60 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Dec 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
88696901000001111 Canagliflozin 50mg / Metformin 850mg tablets 60 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
88697001000001110 Canagliflozin 50mg / Metformin 850mg tablets 60 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Canagliflozin 50mg / Metformin 850mg tablets 60 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Canagliflozin 50mg / Metformin 850mg tablets 60 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Canagliflozin 50mg / Metformin 850mg tablets 60 tablet Has VMP Canagliflozin 50mg / Metformin 850mg tablets true Inferred relationship Existential restriction modifier
Canagliflozin 50mg / Metformin 850mg tablets 60 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Canagliflozin 50mg / Metformin 850mg tablets 60 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Canagliflozin 50mg / Metformin 850mg tablets 60 tablet Has specific active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Canagliflozin 50mg / Metformin 850mg tablets 60 tablet Has specific active ingredient Canagliflozin hemihydrate false Inferred relationship Existential restriction modifier
Canagliflozin 50mg / Metformin 850mg tablets 60 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Canagliflozin 50mg / Metformin 850mg tablets 60 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Canagliflozin true Inferred relationship Existential restriction modifier
Canagliflozin 50mg / Metformin 850mg tablets 60 tablet Has specific active ingredient Canagliflozin hemihydrate true Inferred relationship Existential restriction modifier
Canagliflozin 50mg / Metformin 850mg tablets 60 tablet Has basis of strength substance Canagliflozin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vokanamet 50mg/850mg tablets (Janssen-Cilag Ltd) 60 tablet Is a True Canagliflozin 50mg / Metformin 850mg tablets 60 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start